Research

Researchers at the Hospital Clínic-IDIBAPS show that pregnant women with pathological angiogenic factors benefit from delivery as early as at 34 weeks’ gestation

Researchers from the Hospital Clínic-IDIBAPS led a multi-centre study (MAP study) across Spain, which showed the benefits of women with preeclampsia delivering after week 34 of gestation when they have pathological angiogenic factors.  

Preeclampsia is a disease characterized by hypertension and proteinuria, in other words excess protein in the urine, and it affects 1 in 30 women. This disease is one of the main causes of maternal and neonatal mortality. Preeclampsia often develops into severe forms, giving rise to complications in the mother and the newborn baby. At present, preeclampsia can only be cured by delivering the baby. 
 

Preeclampsia appears in the last two months of pregnancy and, when it occurs, 1 in 10 women has complications